Matching Items (3)
Filtering by

Clear all filters

135584-Thumbnail Image.png
Description
Breast cancer is the leading cause of cancer-related deaths of women in the united states. Traditionally, Breast cancer is predominantly treated by a combination of surgery, chemotherapy, and radiation therapy. However, due to the significant negative side effects associated with these traditional treatments, there has been substantial efforts to develo

Breast cancer is the leading cause of cancer-related deaths of women in the united states. Traditionally, Breast cancer is predominantly treated by a combination of surgery, chemotherapy, and radiation therapy. However, due to the significant negative side effects associated with these traditional treatments, there has been substantial efforts to develop alternative therapies to treat cancer. One such alternative therapy is a peptide-based therapeutic cancer vaccine. Therapeutic cancer vaccines enhance an individual's immune response to a specific tumor. They are capable of doing this through artificial activation of tumor specific CTLs (Cytotoxic T Lymphocytes). However, in order to artificially activate tumor specific CTLs, a patient must be treated with immunogenic epitopes derived from their specific cancer type. We have identified that the tumor associated antigen, TPD52, is an ideal target for a therapeutic cancer vaccine. This designation was due to the overexpression of TPD52 in a variety of different cancer types. In order to start the development of a therapeutic cancer vaccine for TPD52-related cancers, we have devised a two-step strategy. First, we plan to create a list of potential TPD52 epitopes by using epitope binding and processing prediction tools. Second, we plan to attempt to experimentally identify MHC class I TPD52 epitopes in vitro. We identified 942 potential 9 and 10 amino acid epitopes for the HLAs A1, A2, A3, A11, A24, B07, B27, B35, B44. These epitopes were predicted by using a combination of 3 binding prediction tools and 2 processing prediction tools. From these 942 potential epitopes, we selected the top 50 epitopes ranked by a combination of binding and processing scores. Due to the promiscuity of some predicted epitopes for multiple HLAs, we ordered 38 synthetic epitopes from the list of the top 50 epitope. We also performed a frequency analysis of the TPD52 protein sequence and identified 3 high volume regions of high epitope production. After the epitope predictions were completed, we proceeded to attempt to experimentally detected presented TPD52 epitopes. First, we successful transduced parental K562 cells with TPD52. After transduction, we started the optimization process for the immunoprecipitation protocol. The optimization of the immunoprecipitation protocol proved to be more difficult than originally believed and was the main reason that we were unable to progress past the transduction of the parental cells. However, we believe that we have identified the issues and will be able to complete the experiment in the coming months.
ContributorsWilson, Eric Andrew (Author) / Anderson, Karen (Thesis director) / Borges, Chad (Committee member) / School of Molecular Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2016-05
135616-Thumbnail Image.png
Description
Background: High risk types of human papillomavirus (HPV) are known to cause cancer, including cervical (99%) and oropharyngeal cancer (70%). HPV type 16 is the most common subtype. Three antigens that are critical for integration or tumor progression are E2, E6 and E7. In this study, we developed a systematic

Background: High risk types of human papillomavirus (HPV) are known to cause cancer, including cervical (99%) and oropharyngeal cancer (70%). HPV type 16 is the most common subtype. Three antigens that are critical for integration or tumor progression are E2, E6 and E7. In this study, we developed a systematic approach to identify naturally-processed HPV16-derived HLA class I epitopes for immunotherapy development. Methods: K562 cells, which lack HLA expression, were transduced with each HPV16 antigen using lentivirus and supertransfected with HLA-A2 by nucleofection. Stable cell lines expressing each antigen were selected for and maintained throughout the investigation. In order to establish a Gateway-compatible vector for robust transient gene expression, a Gateway recombination expression cloning cassette was inserted into the commercial Lonza pMAX GFP backbone, which has been experimentally shown to display high transfection expression efficiency. GFP was cloned into the vector and plain K562 cells were transfected with the plasmid by nucleofection. Results: Expression of K562-A2 was tested at various time points by flow cytometry and A2 expression was confirmed. Protein expression was shown for the transduced K562 E7 by Western blot analysis. High transfection efficiency of the pMAX_GFP_Dest vector (up to 97% GFP+ cells) was obtained 48 hours post transfection, comparable to the commercial GFP-plasmid. Conclusion: We have established a rapid system for target viral antigen co-expression with single HLA molecules for analysis of antigen presentation. Using HPV as a model system, our goal is to identify specific antigenic peptide sequences to develop immunotherapeutic treatments for HPV-associated cancers.
ContributorsVarda, Bianca Marie (Author) / Anderson, Karen (Thesis director) / Borges, Chad (Committee member) / Krishna, Sri (Committee member) / School of Life Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2016-05
Description

Plasticizers are plastic additives used to enhance the physical properties of plastic and are ubiquitous in the environment. A class of plasticizer compounds called phthalate esters that are not fully eliminated in wastewater treatment facilities are relevant to the ecological health of downstream ecosystems and urban areas due to their

Plasticizers are plastic additives used to enhance the physical properties of plastic and are ubiquitous in the environment. A class of plasticizer compounds called phthalate esters that are not fully eliminated in wastewater treatment facilities are relevant to the ecological health of downstream ecosystems and urban areas due to their ecotoxicity, tendency for soil accumulation, and the emerging concern about their effects on public health. However, plasticizer concentrations in a constructed wetland environment have rarely been studied in the United States, prompting the need for a method of plasticizer quantification in the Tres Rios Constructed Wetlands which are sustained by the effluent of the 91st Avenue Wastewater Treatment Plant in Phoenix, Arizona. The concentrations of four common plasticizer compounds (dimethyl: DMP, diethyl: DEP, di-n-butyl: DnBP, and bis(2-ethylhexyl): DEHP phthalate) at five sites across the wetland surface water were quantified using solid-phase extraction followed by gas chromatography coupled with mass spectrometry (GC/MS). The sampling period included four sample sets taken from March 2022 to September 2022, which gave temporal data in addition to spatial concentration data. Quantification and quality control were performed using internal standard calibration, replicate samples, and laboratory blanks. Higher molecular weight phthalates accumulated in the wetland surface water at significantly higher average concentrations than those of lower molecular weight at a 95% confidence level, ranging from 8 ng/L to 7349 ng/L and 4 ng/L to 27876 ng/L for DnBP and DEHP, respectively. Concentrations for dimethyl phthalate and diethyl phthalate were typically less than 50 ng/L and were often below the method detection limit. Average concentrations of DnBP and DEHP were significantly higher during periods of high temperatures and arid conditions. The spatial distribution of phthalates was analyzed. Most importantly, a method for successful ultra-trace quantification of plasticizers at Tres Rios was established. These results confirm the presence of plasticizers at Tres Rios and a significant seasonal increase in their surface water concentrations. The developed analytical procedure provides a solid foundation for the Wetlands Environmental Ecology Lab at ASU to further investigate plasticizers and contaminants of emerging concern and determine their ultimate fate through volatilization, sorption, photodegradation, hydrolysis, microbial biodegradation, and phytoremediation studies.

ContributorsStorey, Garrett (Author) / Herckes, Pierre (Thesis director) / Childers, Dan (Committee member) / Borges, Chad (Committee member) / Barrett, The Honors College (Contributor) / School of Sustainability (Contributor) / School of Molecular Sciences (Contributor)
Created2023-05